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ABSTRACT 
 
Objective: To determine if applying electroacupuncture at ST 36-37 will lower 
the systolic, diastolic, and mean blood pressures of chronic hypertensive rats.  
Design: A 12-week study on the effect of electroacupuncture was conducted 
from September 2014 to December 2014. The total number of rats used in the 
study was 16 (n=16). The rats were divided into four groups: Electroacupuncture, 
Sham-EA, Hypertensive control, and Normotensive control. All of the rats, expect 
for those in the Normotensive group, were housed in the cold room to induce 
chronic hypertension. After 8 weeks in the cold room, the rats in the  
Electroacupuncture group received electrical stimulation twice a week for 30 min.  
Needles were also inserted into the rats in the Sham-EA group, but there was no 
electric current. The blood pressures of all of the rats were measured once a 
week for 12 weeks. Lastly, the data was analyzed using SigmaStat to perform 
One Way ANOVA and T-tests.  
Result: The initial blood pressures between the 4 groups were similar with a  
difference of less than 5 mmHg. The groups placed in cold rooms showed a 	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significant difference of more than 20 mmHg compared to their initial blood 
pressures (P≤0.05) at week 7. Finally, the blood pressures of the Sham-EA and 
Hypertensive control group did not lower at 12 weeks compared to week 7. 
However, the systolic, mean, and diastolic blood pressures in the EA group 
lowered with a significant difference of greater than 20 mmHg at week 12 
compared to week 7. There was no significant change between the initial and 
final blood pressures for those in the Normotensive group.  
Conclusion: The data showed that systolic, diastolic, and mean blood pressures 
in the Electroacupuncture group lowered significantly at week 12 or after 5 weeks 
of treatment. Thus, we can conclude that electroacupuncture does have a 
beneficial effect in lowering blood pressure in chronically hypertensive rats. 
vii 
 
TABLE OF CONTENTS 
 
 
Title            i 
 
Reader’s Approval Page        ii 
 
Acknowledgements         iii 
 
Abstract          iv 
 
Table of Contents         vi 
 
List of Tables         viii 
 
List of Figures         ix 
 
List of Abbreviations        x 
 
 
Introduction          1 
 
 Causes of High Blood Pressure       
 Statistics on Hypertension    
 Popular Treatments for Hypertension 
 Alternative Treatments for Hypertension 
Specific Aims         5 
Background and Significance       6 
 General Effect of Acupuncture on Blood Pressure 
 Defining Cardiovascular Reflexes 
 Acupuncture Modulates Low Blood Pressure 
 How EA Works  
 Lasting Effect of EA 
viii 
 
Current Study          11 
Methods          12 
  
 General Overview 
 Rats  
 Equipment to Measure Blood Pressure  
 Restraining Rats 
 Procedure for EA Group 
 Procedure for Sham Group 
 Procdure for Control Group  
 
Results          21 
 
 Data Tables  
 Graphs 
 Data Analysis 
 
Discussion           31 
 Limitations  
Conclusion          36 
Appendix           39 
List of Journal Abbreviations        47 
References           48 
Vita            50 
ix 
 
LIST OF TABLES 
 
Table Title Page 
1 Groups 15 
2 Systolic 22 
3 Diastolic 23 
4 Mean  24 
5 Heart Rate 25 
 
  
x 
 
LIST OF FIGURES 
 
 
 
Figure Title Page 
1 Acupoints 12 
2 CODA Machine 17 
3 Systolic Blood Pressure 26 
4 Diastolic Blood Pressure 27 
5 Mean Blood Pressure 28 
 
  
xi 
 
LIST OF ABBREVIATIONS 
BP ................................................................................................... Blood Pressure 
CDC………………………………………………………...Center for Disease Control 
 
CIH…………………………………………………………Cold Induced Hypertension  
 
EA ............................................................................................ Electroacupuncture 
1 
 
INTRODUCTION 
 
Hypertension or high blood pressure is one of the main factors that increases the 
possibility of having heart attacks or strokes. Hypertension results when there is 
too much pressure against the walls of arterial vessels when blood is transported 
throughout the body. If the arterial pressure remains high for a long time, it may 
lead to damages of the heart and also the vessels. High blood pressure is 
especially dangerous for the heart because the heart must work harder than 
normal to pump blood to fuel the organs. As a result, the overworked heart has a 
higher chance of failing in the future when compared to someone who is 
normotensive.  
 
Causes of High Blood Pressure  
There are many causes for high blood pressure and the most common case results 
from the stiffness of the arterial walls. When blood flows through the arterial 
vessels, it exerts a force against the walls. The systolic pressure measures the 
pressure from the heart pumping blood to the aorta; the pressure that is maintained 
by the arterial vessels is called diastolic. Due to old age or plaque in the walls, the 
vessels become less elastic than normal. Thus, the heart has to exert more force 
in order to squeeze the blood through the vessels and deliver it to the target organ 
(AMA 2014). As a result, a less elastic vessel or a vessel that is clogged due to 
poor diet can be dangerous. The heart will have to exert more force and will have 
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to work harder than normal to maintain a constant blood volume. This will result in 
heart failures.  
 
Need for New Treatments for Hypertension 
The Center for Disease Control states that “high blood pressure was the primary 
contributing cause of death for more than 348,000 Americans” (CDC, 2009). 
Currently, about 31% of American adults have high blood pressure. These 
numbers are scary because many American adults will have hypertension in the 
future. If these individuals do not take proper measures to prevent prolonged 
high blood pressure, they may suffer heart conditions and possibly face deaths in 
the future. Another surprising statistics was that only about 47% of the adults 
who have hypertension have their conditions under control (CDC, 2009). Thus, 
many adults who have hypertension are unable to lower their blood pressures to 
a safe status. As a result, many Americans inevitably will have to deal with heart 
conditions and the dangers of having high blood pressure in the future. Thus, 
better treatments that can help lower hypertension are needed to help control 
hypertension for a majority of Americans.  
 
Popular Treatments for Hypertension  
Because hypertension is a widespread problem in America, there are many 
treatments available to control and essentially lower an individual’s blood 
pressure. The most common treatment is using prescription medications. Several 
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types of medications exists and it is challenging to determine which type of 
medication to take. Some of the most common types are ACE inhibitors, Beta-
blockers, Vasodilators (AHA, 2015). These drugs have different targets, but the 
ultimate goal for all of them is to lower blood pressure. Furthermore, it is hard for 
one to pinpoint the exact reason for hypertension because it can be caused by 
several factors. Some people’s heart might naturally exert more force to pump 
blood out from the ventricles and into the aorta because they have thick 
ventricles. As a result, their systolic pressure is higher than normal. Other people 
may have very stiff arteries, which reduce the area that blood can flow. Thus, the 
blood in the arteries may exert more pressure and increase the systolic and 
diastolic pressure for the person. Finally, high blood pressure can be caused by 
over excitation of the sympathetic nervous system. Thus, there are many 
medications that focus on reducing the sympathetic and increasing the 
parasympathetic response to control the heart. Although there is a plethora of 
medications available, overmedication can be a problem. Patients may 
experience adverse reactions or side effects from the drugs.  
 
Alternative Treatments for Hypertension 
Besides preventative methods such as having good diet and maintaining healthy 
lifestyles, there are several complementary medicine approaches to treating 
hypertension. In an era when overmedication is a serious problem, many people 
are seeking alternative routes for treating their problems. In the review article by 
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Richard Nahas, he states that coenzyme Q10, dark chocolate, Qigong, 
melatonin, and acupuncture are several alternative approaches that have shown 
to reduce hypertension (Nahas, 2011). However, more research is needed to 
provide empirical evidence for these methods. Thus, the focus of the thesis 
research is to provide empirical evidences that support the effectiveness of 
electroacupuncture in lowering blood pressure.  
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SPECIFIC AIMS 
To determine the effectiveness of electroacupuncture on lowering blood pressure 
in hypertensive rats. Specifically, to determine if applying electroacupuncture 
twice a week at acupoints ST36-37 will reduce the systolic, diastolic, and mean 
blood pressure for EA, Sham-EA, and CIH Control group rats.  
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Background and Significance 
 
Acupuncture has been a key treatment option in Eastern medicine, especially in 
China. The use of acupuncture originated thousands of years ago and it is still 
practiced today by some practitioners. Acupuncture has many alleviating effects, 
including the treatment of cardiovascular diseases. Unfortunately, many Western 
physicians are less likely to recommend the treatment due to the lack of research 
and evidence proving the effectiveness of acupuncture. Thus, there are 
questions to be answered such how many mmHg of blood pressure can 
acupuncture reduce? How many times should a person undergo acupuncture 
treatments a week? Will acupuncture be an effective alternative way to treat 
hypertension and ultimately heart disease?  
 
General Effect of Acupuncture on Blood Pressure 
From previous studies, the data concluded that acupuncture can both increase 
and decrease the blood pressure. It acts as a modulator for abnormal blood 
pressure. Acupuncture in points P5-P6 overlying the median nerves can lower 
elevated blood pressure in hypertensive rats (Tjen-A-Looi, Guo, Li and 
Longhurst, 2013).This fact is significant to this study because we can test the 
preliminary data and determine if EA is useful in CIH rat models. EA can lower 
blood pressure when needles are applied to points that are connected to the 
sympathetic nervous system and it sends signals to regulate the sympathetic 
output. As a result, applying EA at points that can send strong signals to the 
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sympathetic nerves will have a larger effect on lowering the blood pressure than 
points that have little input.  
 
Defining Cardiovascular Reflexes 
The human body has a natural control system that modulates the change of 
blood pressure. The cardiovascular reflex system allows the body to maintain a 
stable arterial blood pressure by sending impulses to modulate the blood 
pressure. When the arterial blood pressure is high, the reflex system send 
impulses and provide a negative feedback loop to lower heart rate and ultimately 
decrease blood pressure. When the blood pressure is low, the cardiovascular 
reflexes will increase its excitatory signals and increase heart rate to restore the 
normal blood pressure. EA plays an important role in the cardiovascular reflexes 
because it inhibits the cardiovascular excitatory reflex and inhibit the sympathetic 
response.  
 
Acupuncture Modulates High Blood Pressure  
Applying EA at specific acupoints such as S36-37 and P5-6 lowers the 
sympathoexcitatory response and ultimately thwart the increase in blood 
pressure. EA is proven to inhibit elevated blood pressure by blocking premotor 
sympathetic neural firing in the rVLM. RVLM is important for EA because it is the 
primary regulator of sympathetic nervous system. The effect is long-lasting and 
maintains for more than an hour (Li and Longhurst, 2011). The arcuate nuclei 
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plays an important role as it interacts with rVLM and vlPAG in the midbrain. 
When specific acupoints are stimulated, neuronal activity in the arcuate and 
vlPAG is detected (Li et al…, 2006). As a result, the stimulation of arcuate 
nucleus and the signaling pathway to the vlPAG contribute to the EA mechanism.  
 
The vlPAG sends inhibitory signals to the premotor sympathetic neurons in the 
rVLM, which reduces sympathetic output and reflex elevations in blood pressure 
(Tjen-A-Looi et al.., 2006). The main pathways involve endorphins and opioid 
receptors located on rVLM to reduce sympathetic response on the heart. The 
neurotransmitters that are released after EA stimulation are opioids, GABA, and 
serotonin in rVLM. Studies found that enkephalinergic neurons in the rVLM and 
endorphinergic neurons in the arcuate nucleus are activated by EA (Li and 
Longhurst, 2011). Because there are receptor sites for these chemicals in rVLM, 
it can be predicted that enkephalins and endorphins are released after EA 
stimulation. Furthermore, EA reduces the release of GABA in vlPAG. Normally, 
GABA reduces vlPAG activity, which increases the sympathetic activity of rVLM. 
Thus, EA increases the production of GABA and ultimately increases the activity 
of the vlPAG in inhibiting sympathetic response. There are numerous 
neurotransmitters that are involved after EA stimulation. Most of the 
neurotransmitters are released in in the vlPAG or rVLM after EA is applied.  
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Overall, applying EA at special acupoints such as P5-6 or ST 36-37 will induce a 
signal pathway that ultimately reduce cardiovascular sympathetic activity. Studies 
predict that simulation by EA sends signal to the arcuate nucleus. The arcuate 
nucleus induces and increases the activity of vlPAG. During this time, opioids 
and neurotransmitters are released; the opioid receptor plays a role in reducing 
sympathetic activity. Furthermore, reduced GABA signal increase the activity of 
vlPAG and decreases the activity of rVLM. Finally, reduced activity of the rVLM 
causes a drop in blood pressure.  
 
How EA Works 
Electroacupunture uses a small electrical current that flows through a needle. 
The treatment is applied twice a week for 30 min. The electrical current is sent 
from a device that can control the voltage of the electrical current. Previous 
studies have found that electroacupuncture is the most effective when using low 
current and low frequency (Li and Longhurst 2011). The device allows the users 
to control the transmitted voltage. In this study, the acupoints of interest are S36-
37. Points 36-37 overlies the peroneal nerve and is associated with inhibition of 
sympathoexcitatory responses (Li and Longhurst 2011).  
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Fig 1: Acupoints. The diagram displays the different acupoints on the human body. 
The S36-37, located at the deep peroneal nerve, is the focus of the study  
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CURRENT STUDY  
 
This paper analyzes the results of a 12 week study on the effects of 
electroacupuncture in lowering the blood pressure of chronically hypertensive 
rats. The research will focus on the amount of blood pressure drop in systolic, 
diastolic, and mean blood pressures for four groups. Although there were some 
related preliminary studies, this study provides a more comprehensive and 
controlled data that analyzes not only the systolic, but also diastolic and mean 
blood pressure changes. We hypothesize that CIH rats treated with 
electroacupuncture two times a week for 30 minutes will show a significant 
decrease of blood pressure than those that were not treated with 
electroacupuncture. This research may provide more concrete empirical data that 
will further support the use of electroacpuncutre as an alternative treatment for 
hypertension.  
 
METHODS 
 
General Overview 
The rats were cultivated in a storage room at normal 25 °C until they grew bigger. 
We measured the initial blood pressures of the rats for record. Then, most of the 
rats were placed into the cold room (6°C) for the rest of the experiment. The rats 
were placed in the cold room in order to increase their blood pressure (Fregly, 
12 
 
Kikta, Threatte, 1989). The cold room environment induces chronic instead of 
situational hypertension for the rats. Our aim was to determine the effect of EA 
on blood pressure depression, so we wanted to insure that the rats had stable 
and chronic hypertension before they received treatment. Also, it would not be 
feasible to do the experiment when the rats did not have chronic hypertension 
because their blood pressures may vary too greatly and it would be hard to 
compare the data with the control group. 
 
The rats were separated into four groups: CIH EA, CIH Sham, CIH control, and 
Normotensive control. Electroacupuncture was applied twice a week for 6 weeks 
to chronically hypertensive rats. The rats received electrical stimulations at 
acupoints ST 36-37 on both sides of their hind limbs. The acupoints are located 
in the deep peroneal nerves of the rats.  A day after the second EA treatment, 
the blood pressures for the rats were measured using a tail cuff machine. We 
continued to measure the blood pressures of the rats every week and recorded 
the systolic, diastolic, and mean arterial blood pressure.  
 
Rats 
We used 16 Sprague-Dawley (125-149 g) rats for the experiment. The rats were 
born on July 2014 and we received them at the end of August 2014. The initial 
blood pressures and weights of the rats were measured. Afterwards, 14 rats 
were placed in the cold room at 6 °C. 2 rats were randomly selected to be placed 
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in the normal storage room at 25 °C. The rats were placed in the cold room to 
induce chronic hypertension with increase in sympathetic activity, a common 
factor that contributes to increase in blood pressures in patients with 
hypertension. In previous studies, rats who had stress-induced hypertension 
were not only found to have increased sympathetic activity, but also high levels 
of plasma catecholamine, angiotensin II, and corticosterone (Sun 2005). These 
hormones are often responsible for the increase in blood pressure in humans, 
especially angiotensin II. Furthermore, cold-induced hypertension is 
epidemiologically important because clinical observations established that people 
have higher incidences of cardiovascular disease in cold weathers. Studies have 
also found that plasma renin levels are increased during cold exposure (Sun 
2001). As a result, CIH rats are similar to human hypertension due to the 
increased level of sympathetic activity, angiotensin II, and renin during long cold 
exposures. Cold-induced rat models are a great way to represent chronic 
hypertension that doesn’t require genetic, hormonal, or surgical manipulations to 
the rat. This is important because we wanted to show that the EA treatment 
worked for genetically normal rats that displayed stress induced hypertension 
modeling that of humans. Thus, we chose the cold-induced hypertensive rat 
model instead of other models such as salt-sensitive or transgenic models. In this 
experiment, the rats were randomly divided into 4 groups as shown:  
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Table 1: Groups. The table shows the 4 different groups and the rats in the group for 
the experiment. 
Normotensive Control CIH Control CIH-Sham EA CIH-EA 
Rats: 2, 3 Rats: 4,5,16 Rats: 1,6,7, 14, 
15 
Rats: 8,9,10,11, 
12,13 
 
The rats in the Cold-Induced Hypertension (CIH) group were all housed in the 
cold room at 6°C. Each morning, around 9:00 – 10:00 a.m., students retrieved 
the rats from the cold room and transported the rats back to the laboratory. The 
trip involved the rats to be covered in black plastic bags and transported outside 
of the room. The rats were carried on a metal cart.  
 
Measuring Blood Pressure  
Before measurement, the rats were housed in the lab room (25°C) for 15-20 
minutes before their blood pressures were taken. The measurements were not 
done in the cold because the cold room was not accessible to do the experiment. 
The order that we measured the rats’ blood pressures was random and changed 
every week. We tried to do the measurements as efficiently as possible, but if the 
readings were not accurate, we had to run the program again. As a result, some 
cold room rats sat in 25°C longer than 20 minutes before their blood pressures 
were measured.  
 
15 
 
We used a tail-cuff apparatus from Kent Scientific that measured the blood 
pressures of the rats (CODA System, Kent Scientific, Torrington, CT). The non-
invasive apparatus uses volume pressure detector to measure the blood flow in 
the rats’ tails. When the occlusion cuffs are deflated, sensors in the cuffs monitor 
the blood pressure. The cuffs must be calibrated before every usage to make 
sure that the rubber inside the cuffs are not broken. To calibrate, the cuffs must 
be submerged under water in order to test its ability to detect volume change. 
Once the program stated that the cuffs passed the test, the cuffs can be used on 
the rats. The cuffs have a hole in the middle where the rats’ tails can slide 
through. The occlusion cuffs were circular and the Volume Pressure cuffs were a 
cylinder shape. The conscious rats were placed in a plastic restrainer ranging 
from small to large size. After they were placed in the restrainer, the rats rested 
for 10 minutes before the cuffs were placed on their tails. The occlusion cuffs 
wrapped around the tails and it was placed superior to the end of tail and near 
the anus. The volume pressure cuffs wrapped around the tail of the rats and 
were placed right below the occlusion cuffs. Once the cuffs were placed on the 
rats, we ran the program and the blood pressure of the rat was taken for 15 
sessions. The sessions that showed a flow of 0 or had a FALSE reading were 
deleted. Those readings were deleted because they were errors due to the 
machine and did not provide an accurate recording of the blood pressure. The 
blood pressure of each rat was measured on an average of 3 times. We 
averaged the systolic, diastolic, and mean arterial blood pressures in each of the 
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sessions. We recorded the average blood pressures from three measurements 
on the final tabulated data.  
 
Fig 2: CODA Machine. CODATM Standard Machine Tail Cuff apparatus.  
 
 
 
Restraining Rats  
Before the rats were given EA, the rats needed to become accustomed to 
experimental handling and EA procedure. The rats in the EA and Sham group 
were restrained using towels. The towels had four holes for the limbs. The towels 
wrapped around the rats and allowed their limbs to dangle on the outside. Each 
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rat was restrained using a separate towel sling to hold the rats in place and 
prevent them from moving around. Then, the towel was clipped onto a metal bar, 
which secured the rat. The rats safely hung from the metal bar, allowing easy 
access to their limbs for acupuncture. The rats were restrained twice a week for 
30 min intervals. It was necessary that the rats experience the same handling 
procedures as they do during real EA treatment. Thus, the rats must be handled 
with care and there must be two training sessions every week to model the real 
EA schedule. Finally, acupuncture needles (Lekon disposal 40 gauge needles, 
0.16mm diameter) were inserted into P36-37 for a short time period, so that the 
rats become familiarized with the sensation of needles. However, the needles 
should be removed after couple of seconds to prevent potential healing effects.  
 
Procedure for EA Group  
Rats in the EA group were treated twice a week for 30 min. The rats were 
retrieved from the cold room in the morning and allowed to rest for at least 30 
min at room temperature. Then, the rats were put in the towel sling and clipped 
onto the metal bar. Acupuncture needles were inserted at an angle at the P36-37 
located between the knee and shin region of the rats’ hind limbs. To insert the 
needle properly, we needed to locate the knee bone. Then, we found the muscle 
area that was adjacent and slightly posterior to the knee bone. We inserted one 
needle at an angle around the muscle region. We inserted another needle, 
slightly below the first, at a parallel to the first needle. There should be two 
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needles on each hind limb. The needles should not touch each because that 
could affect the electrical current running through the needles. The same 
procedure should be repeated for the other limbs.  
 
Each of the needles should be connected to an electrical wire that sends current 
from a stimulator (Grass, model S88, W. Warwick, RI, USA). The machine should 
only be turned on after all of the needles are properly inserted into the limb. Each 
of the wire connects to a separate input on the stimulator, which allows the 
voltage for each pair of needles on the limbs to be manipulated separately. For 
safety, the voltage for each wire should be turned down to 0 V to prevent 
shocking both the rats and the handler. The voltage of each pair of needles was 
adjusted until we saw the toes of the rats expand vertically (posterior to superior) 
as a response to the stimulation. If the rats’ toes expanded horizontally (left to 
right), then the needles were not inserted in the correct location and they must be 
adjusted. The voltage usually ranged from 2 to 5 Volts. Any voltage greater than 
8 Volts was too high and we readjusted the location of the needles.  
 
After both of the hind limbs displayed good responses to the EA stimulation, the 
timer was set for 30 min. The rats were left untouched for 30 min unless they 
moved too much and the needles needed to be reinserted. It is important to 
make sure that the adjacent needles are not touching each other during the 
treatment. After 30 min, the stimulator was turned off. We made sure to not touch 
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the needles until the power was completely off in order to prevent injuries. The 
needles were slowly removed from the hind limbs of the rats. The rats were 
unclipped from the metal bar and the towel sling was removed from the rats. The 
rats that had treatment were returned back to their cages. Then, the rats were 
returned back to the cold room during late afternoon when the experiment for the 
day was completed.  
 
Procedure for Sham-EA Group 
The Sham-EA group was also treated twice a week for 30 min each time. The 
sham group’s main purpose was to mimic the procedure of the EA group without 
implementing the actual electrical stimulation. The procedure for the Sham group 
was relatively similar to that of the EA Group. First, we harnessed the rats using 
a towel sling. Then, we clipped the top of the sling to a metal bar using a metal 
clipper. When one rat was properly secured, we harnessed and prepared the 
other rats in the Sham group. We inserted needles into both of the rats’ hind 
limbs at ST36-37. The two needles were parallel and adjacent to the knee region 
of the rats. After we inserted the needles, the timer was set for 30 min. The 
needles were removed from the rats after 30 min and the rats were returned to 
their allocated cages. The rats were returned to the cold room in the late 
afternoon.  
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Procedure for the Control  
The CIH control group were housed in the cold room and retrieved on 
Wednesdays to measure blood pressure every week. The CIH control group rats 
were placed on the cart for 15-20 min before tail cuffing. Their blood pressures 
were measured once every week.  
 
The Normotensive control group was housed in the vivarium at room temperature 
(25°C). The group of rats was retrieved once a week in order to measure their 
blood pressures using the tail cuff machine.  
 
Data Analysis 
We chose to do One Way ANOVA test to determine if there was significant blood 
pressure changes within one group during the 12 weeks. The main points we 
focused on was the initial blood pressures, the blood pressures right before EA 
treatment started, and the final blood pressures after EA. If some groups failed 
the ANOVA test due to small sample size, we performed T-tests within one 
group, such as the EA group, by comparing the BP at different timelines. The one 
group T-test compared week 3 with 7 and week 7 with 12. We also performed T-
test to compare EA group with another group at three different time points: week 
3, 7, and 12. Week 3 and week 7 were specifically chosen to analyze because 
week 7 was the last week before treatment started. Thus, it was an important 
check point to determine if we were able to mimic chronic hypertension in cold 
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induced rats. Week 3 was chosen due to statistical reasons. Because some 
blood pressure measurements were missing from week 1, we had to select week 
2 or week 3 to represent initial blood pressures. Week 3 worked better because 
blood pressures during that week were more stable and there were less 
anomalies. Thus, week 3 was a better point to set as a reference for initial or 
early blood pressures. 
 
RESULTS  
 
The experiment started on September 8, 2014. The cold-induced rats were put 
into a cold room for 7 weeks until October 22, 2014. The EA treatments started 
on the week of October 27, 2014 or week 7. The EA treatment lasted for 5 weeks 
until November 26, 2014. The initial blood pressure for some rats were not 
available because they were too small to fit into the blood pressure cuffs. The 
blood pressure of CIH control, Sham-EA, and EA group increased more than 20 
mmHg after they were placed in the cold room for 7 weeks (refer to BP of Week 
1 to Week 7). The rats in the Normotensive group showed a stable systolic blood 
pressure around 120-130 mmHg. After 5 weeks of EA treatment, the blood 
pressure of the rats in the EA group showed a drop of more than 20 mmHg for 
systolic blood pressure compared to those in the CIH control and Sham-EA 
group (refer to BP of week 7 to week 12). Although the total sample size was 
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relatively small with 6 EA rats, the difference in blood pressure of the EA group 
was significantly different from that of Sham-EA and Normotensive.  
 
After week 8, the rats in the EA group showed steady decrease in blood 
pressure. Whereas, the blood pressure in the CIH control and Sham-EA group 
remained high until the end of the experiment. We also measured the blood 
pressure at 24, 48, and 72 hours after the last EA treatment to note any 
immediately blood pressure changes after treatment. The blood pressures of the 
EA group increased slightly after 24 hours, but very minimal of less than 5 
mmHg. The blood pressure of the Sham-EA and CIH control decreased (less 
than 10 mmHg after 72 hours), but the overall blood pressures were still relatively 
higher than that of the EA group.  
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Table 2: Systolic. The table shows the systolic blood pressure (mmHg). 
  
*HCONT= Hypertensive Control; EA= Electroacupuncture; NC= Normotensive Control  
RAT # WEEK 1 WEEK 2 WEEK 3 WEEK 4 WEEK 5 WEEK 6 WEEK 7 
2-NCONT N/A 139 116.5 114.3 145.1 125.8 132 
3-NCONT N/A 128.75 143 123.3 119.6 163.6 128 
4-HCONT 129.17 159.6 166.5 137.8 152.2 147.3 144.6 
5-HCONT 111.8 131.9 126.5 128.4 124.1 120.2 160 
16- HCONT 141.4 115.7 124.8 145.3 162.7 163.4 162 
1-SHAM N/A 162 147.8 146.5 141.3 170.8 169.7 
6-SHAM N/A 146.3 140 156.7 122.8 152.3 165.15 
7-SHAM N/A 164.2 129 147.1 131.9 146.8 155.05 
14-SHAM 143.5 132.5 143.6 144.2 150 156.3 162.3 
15-SHAM 143 133.3 141.7 151.9 152.3 149.3 155.7 
8-EA 135.5 129 144.4 130.7 140.4 145 161 
9-EA 123.3 106.8 124 125 112 162.3 156.85 
10-EA 145 147.1 139.2 137 162 152.3 163.8 
11-EA 151 154.9 139.1 150.3 155.8 169.6 170.4 
12-EA 127.8 133.25 137.3 135 152.7 149.5 144.8 
13-EA 119.1 120 126.3 143 155.7 150.5 146.6 
RAT # WEEK8 
WEEK 
9 
WEEK 
10 
WEEK 
11 
WEEK 
12 
24 
HOURS 
48 
HOURS 
72 
HOURS 
2-NCONT N/A 134.5 128.8 133.7 129 N/A 131.7 135.8 
3-NCONT N/A 117.3 139.5 127.3 131.7 N/A 136 124.4 
4-HCONT 161.8 164 162.6 158.3 162 159 151.8 150.4 
5-HCONT 174 152.5 159.4 153.3 153.3 153 157.8 155.7 
16-HCONT 147.8 162.3 161.5 163.8 163.6 N/A N/A N/A 
1-SHAM 173.5 173.3 165.2 161 182.5 179.3 161 168 
6-SHAM 162.4 177.2 151.3 161 167 162 160.9 166.3 
7-SHAM 168.8 156 148 169.7 172.7 156.7 163.3 161.7 
14-SHAM 151.3 159.2 155 157.3 161.3 N/A N/A N/A 
15-SHAM 164 160.3 153 155.7 154.3 N/A N/A N/A 
8-EA 149 146.3 144 129 122.6 137.5 128 122.7 
9-EA 145.3 144 138.3 126.3 122.6 139.5 130 133.8 
10-EA 134.3 137.3 139 147 139.8 142.5 139.3 140.3 
11-EA 125.3 143 144 145.6 138 140 142.3 144.3 
12-EA 144 134.5 127.2 128.8 128.1 N/A N/A N/A 
13-EA 136 141.8 136.7 137.5 140.5 N/A N/A N/A 
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Table 3: Diastolic. The table shows the diastolic blood pressure (mmHg). 
RAT # WEEK 1 
WEEK 
2 
WEEK 3 WEEK 4 WEEK 5 WEEK 6 WEEK 7 
2-NCONT N/A 99 75.5 73.5 102.9 91.4 90.2 
3-NCONT N/A 78 95.5 91.3 82 114.3 80.5 
4-HCONT 97.5 111.9 119.8 98.6 106.7 100.2 103.3 
5-HCONT 78.3 92.6 85.5 78.4 82.9 80 102.8 
16-HCONT 102.8 77.2 84.3 95 105.4 118.5 118 
1-SHAM N/A 112.4 108 95 103 117.6 113.3 
6-SHAM N/A 104.9 90.2 106.1 82.5 111.3 113.4 
7-SHAM N/A 116.8 85.8 92.6 90.9 101.3 105.2 
14-SHAM 101.8 83 94.2 96.4 99.5 114 112.8 
15-SHAM 107.5 85.7 96.7 109.3 93 108.6 107.2 
8-EA 105.3 92 105.4 93.7 95 109.5 107.2 
9-EA 89 72.5 88 76.3 83 128 109.7 
10-EA 104.8 101.5 92.7 94 104 101.4 116.9 
11-EA 112.5 102.7 100.4 107 101 116.3 109.2 
12-EA 93.4 94.8 81.8 92.8 108.3 98.5 103.7 
13-EA 84 78.7 84 85 97.7 109.8 97.6 
  
*HCONT= Hypertensive Control; EA= Electroacupuncture; NC= Normotensive Control 
RAT # WEEK8 
WEEK 
9 
WEEK 
10 
WEEK 
11 
WEEK 
12 
24 
HOURS 
48 
HOURS 
72 
HOURS 
2-NCONT N/A 91.9 90 89.7 89.2 N/A 100.7 100.5 
3-NCONT N/A 76.5 95.4 81.5 75 N/A 76 80.4 
4-HCONT 112 106 107.2 107 116 112 102.8 106 
5-HCONT 122.2 95.3 100.6 102.7 104.7 113.8 109.3 91.7 
16-HCONT 102.3 113.3 112.3 116.8 112 N/A N/A N/A 
1-SHAM 124 122 111.2 107 127.3 125.3 103.7 114 
6-SHAM 126 115.4 100.5 129 106.2 123.2 114.1 113.3 
7-SHAM 116.3 115 100.3 123 127.9 118.3 128.3 107.7 
14-SHAM 106.1 118.5 110.6 110.5 111.3 N/A N/A N/A 
15-SHAM 133 107.8 112.3 104 101.4 N/A N/A N/A 
8-EA 109.7 107.8 102.8 93 88.4 99.8 87.5 78.7 
9-EA 97.7 96 103 70.8 77.4 113.8 93.3 92.5 
10-EA 92.5 116.3 90 117.7 100 98 97 76 
11-EA 78.8 87 100.3 99.3 78 88 84.3 85 
12-EA 99 99.5 93.4 95.6 91 N/A N/A N/A 
13-EA 86 94.2 99.7 89.8 115 N/A N/A N/A 
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Table 4: Mean. The table shows the mean blood pressure (mmHg). 
RAT # WEEK 1 WEEK 2 WEEK 3 WEEK 4 WEEK 5 WEEK 6 WEEK 7 
2-NCONT N/A 112 89 86.7 116.6 102.5 103.8 
3-NCONT N/A 94.5 111 101.6 94.3 130.4 95.8 
4-HCONT 107.7 127.3 135.2 111.4 121.7 115.3 116.5 
5-HCONT 89 105.3 98.9 94.8 96.3 93.1 121.5 
16-HCONT 115.3 89.8 97.3 111.5 124.1 133.3 132 
1-SHAM N/A 128.8 121 111.8 115.5 135.2 131.8 
6-SHAM N/A 118.3 106.6 122.6 95.5 124.5 130.15 
7-SHAM N/A 132.2 99.9 110.4 104 116.1 121.6 
14-SHAM 115.5 99 110.4 112 116 127.7 129 
15-SHAM 118.8 101.3 111.3 123 112.5 121.9 123.2 
8-EA 115.3 104.4 118.2 105.7 109.9 121 124.9 
9-EA 100.1 83.75 99.5 92.3 92.4 139 125.3 
10-EA 118 116.3 107.8 108 123.2 118 132 
11-EA 124.8 119.2 112.9 121 118.8 133.7 129.1 
12-EA 104.4 107 100 106.8 122.7 113.5 118.8 
13-EA 95.2 92.17 98 104 116.7 123.3 113.4 
*HCONT= Hypertensive Control; EA= Electroacupuncture; NC= Normotensive Control 
  
RAT # WEEK8 
WEEK 
9 
WEEK 
10 
WEEK 
11 
WEEK 
12 
24 
HOURS 
48 
HOURS 
72 
HOURS 
2-NCONT N/A 105.6 102.5 104 102 N/A 110.7 111.8 
3-NCONT N/A 89.8 109.9 96.7 93.7 N/A 95.7 94.8 
4-HCONT 128.3 125 125.2 123.7 131 127.3 118.8 120.4 
5-HCONT 139.4 114 120 119.3 120.7 126.5 125 112.7 
16-HCONT 117.2 130 128.3 132.2 128.6 N/A N/A N/A 
1-SHAM 140 138.5 128.8 124.7 145.56 143 122.3 131.5 
6-SHAM 138 135.6 117 139.2 126.2 135.8 129.4 130.7 
7-SHAM 133.5 128.7 116 138.3 142.4 131 139.7 125.7 
14-SHAM 120.9 131.7 124.9 125.8 127.8 N/A N/A N/A 
15-SHAM 143 125 125.6 120.7 118.6 N/A N/A N/A 
8-EA 122.7 120.3 116.4 104.5 99.4 112 100.8 93 
9-EA 113.2 111.7 114.7 89 92 122 105.3 105.8 
10-EA 106.2 123 105.8 127 113 112.5 110.7 97 
11-EA 94 105.5 114.7 114.7 116.7 105 103.3 104.3 
12-EA 113.7 110.8 104.4 106.4 103.1 N/A N/A N/A 
13-EA 102.4 109.8 111.7 105.3 104.3 N/A N/A N/A 
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Table 5: Heart Rate. The table shows the heart rate (bpm). 
RAT # WEEK 1 WEEK 2 WEEK 3 WEEK 4 WEEK 5 WEEK 6 
2-NCONT N/A 376 496.5 357.5 496 367.5 
3-NCONT N/A 437.8 486 360 359 364.1 
4-HCONT 372.8 407.5 444.5 380 370 414.5 
5-HCONT 433.5 387.5 404.8 389.2 359 407.5 
16-HCONT 352 444.1 427.5 398 457 453.1 
1- SHAM N/A 441.4 413.3 454.3 406.5 454.6 
6-SHAM N/A 435.6 404.8 414.6 414 413 
7-SHAM N/A 445.8 358.3 383.4 399.2 365.3 
14-SHAM 443 441.7 417 404.7 410.6 444.3 
15-SHAM 420 423.4 474.5 439.8 413.5 438.3 
8-EA 462 432.2 441.4 384.3 403 377.5 
9-EA 437.4 413.5 420 368 426.9 379.3 
10-EA 399.2 426.6 385.5 480 404.3 379 
11-EA 406.4 410 359 400.3 376.4 412.6 
12-EA 379 439.7 452 389 491.3 403.3 
13-EA 376 467 417 392 389.7 399 
 
*HCONT= Hypertensive Control; EA= Electroacupuncture; NC= Normotensive Control 
 
RAT # WEEK 7 WEEK8 WEEK 9 WEEK 10 WEEK 11 WEEK 12 
2-NCONT 395.8 430.6 361.1 414.4 357.2 444.3 
3-NCONT 417.7 352.2 465.3 460.5 484.7 475.7 
4-HCONT 402.9 347 357.5 373.3 335 340 
5-HCONT 486.5 373.5 367 416 345.5 334.8 
16- HCONT 437.4 400 433.3 458 361.1 466.6 
1- SHAM 458.1 421.8 419.5 465 423.7 466.5 
6-SHAM 356.6 434.6 357.8 422.2 407.2 399.2 
7-SHAM 470.7 499.3 417 365.3 486.5 405 
14-SHAM 373.2 437.2 416 459 440 465.5 
15-SHAM 445.8 402.2 384.3 394.5 355.5 481.4 
8-EA 410.6 466 391.8 454.3 354.5 459.5 
9-EA 368.8 391.8 400.8 368.3 378 405.5 
10-EA 374.1 428.7 400 398.3 433.8 421 
11-EA 339.7 400.5 376.3 412.7 453.7 428.7 
12-EA 361 373.6 554.2 464.4 421 406.5 
13-EA 350 415.7 402.4 439.2 484 483.6 
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Figure 3: Systolic Blood Pressure. Graph representing the systolic blood 
pressure for Normotensive (n=2), CIH control (n=3), Sham-EA (n=5), EA (n=6). 
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Figure 4: Diastolic Blood Pressure. Graph representing the diastolic blood 
pressure for Normotensive (n=2), CIH control (n=3), Sham-EA (n=5), EA (n=6).  
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Figure 5. Mean Blood Pressure. Graph representing the mean blood pressure 
for Normotensive (n=2), CIH control (n=3), Sham-EA (n=5), EA (n=6).  
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Initially, the rats used in the EA group had similar blood pressures to the rats 
used in the other 3 groups. Thus, the rat models we used in the EA group did not 
differ much in initial blood pressure compared to the other three groups. At week 
3, there was a significant, but very minimal systolic blood pressure difference of 
less than 6 mmHg between EA, Sham, Hypertensive control, and Normotensive 
control group (P>0.05). This same trend was shown for diastolic and mean blood 
pressures.  
 
When we compare the blood pressure difference at week 7 between EA, Sham-
EA, CIH control group, the blood pressure difference was significant, but less 
than 5 mmHg. However, the blood pressure difference compared to the 
normotensive group was greater than 20 mmHg. Thus, the EA group of rats had 
elevated blood pressures compared to the rats not housed in the cold room. The 
3 rat groups in the cold room showed an elevated blood pressure at the start of 
week 8 (when EA treatment started) compared to the normotensive rats.  
 
T-tests across groups showed a significant and large difference between the 
blood pressure of EA compared to that of Sham-EA and CIH control at week 12. 
The difference in systolic pressure was greater than 27 mmHg. The difference 
demonstrated that the final blood pressures for the EA group at week 12 was 
significantly lower than the final blood pressures for the Sham-EA or CIH control 
group. In contrast, T-tests at week 12 between EA and Normotensive control 
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showed a significant, but small difference of less than 2 mmHg for systolic blood 
pressure. A greater difference was shown for diastolic and mean, but the overall 
difference in blood pressures was minimal. Thus, we can conclude that the blood 
pressures shown by the EA treatment group eventually decreased and modeled 
the blood pressures of normotensive rats at week 12. 
 
DISCUSSION  
 
The purpose of this experiment was to determine if electroacupuncture plays a 
role in lowering blood pressures of chronic hypertensive rats. The data analysis 
is presented in Appendix A. By analyzing the data, we found that there was a 
significant difference greater than 20 mmHg among the systolic blood pressures 
of those in the EA group and those in the CIH control or Sham-EA group at the 
end of the 12 week study.  
 
First, we were successful in creating a chronic hypertensive rat model by placing 
the rats in the cold room. There was a significant difference in systolic, diastolic, 
and mean blood pressures from week 3 to week 7. For the rats housed in the 
cold room, their blood pressures all increased from week 3 to week 7. The trend 
applied for systolic, diastolic, and mean blood pressures. Because the rats were 
already in the cold room for couple of weeks, the blood pressure represented by 
week 3 may have been higher than the actual initial blood pressure of the rats. 
32 
 
Thus, the actual difference between the initial blood pressure and the blood 
pressure at week 7 may have been greater. Even if this was true, it will still 
demonstrate that we were successful in inducing chronic hypertension because 
the increase in blood pressure would have been greater than the one shown in 
the data analysis. The cold induced hypertensive model was appropriate for this 
study because we wanted to study the effects of EA in non-genetically, surgically, 
or hormonally altered rats. Because the study is preliminary, we wanted to make 
sure that EA worked in functionally normal rats before it was tested for altered 
rats. Also, this model is appropriate because cold induced hypertension will 
produce responses and hormones that mimic that of human hypertension.  
 
One issue that could have affected the results was that the cold induced rats 
were sitting in 25°C for more than 15 minutes before their blood pressures were 
taken. Although some rats were out of the cold room for a long time, their blood 
pressures did not significantly decrease. This decrease in blood pressure was 
very minimal and insignificant compared to the large differences in the blood 
pressure drop of the EA group. The CIH rats should not have had a significant 
decrease in blood pressure when they are removed from the cold room for less 
than 1 hour. Studies showed that CIH rats did not return to pre-cold exposure 
blood pressure levels even after 4 weeks (Fregly 1989). We can attribute the 
drop in the blood pressure to the success of the EA treatment and not to the 
small decrease of blood pressure from removal of the cold room.  
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Ultimately, we were able to support our hypothesis stating that 
electroacupuncture treatment at ST 36-37 can cause a decrease in the systolic, 
diastolic, and mean blood pressures of rats. The data analysis showed that within 
the EA group, the blood pressures between week 7 and week 12 had a 
significant difference greater than 20 mmHg for systolic, diastolic, and mean 
blood pressures. However, the data showed that the difference between week 7 
and 12 for the Sham group was less than 6 mmHg for systolic, diastolic, and 
mean blood pressure. The same trend was seen for CIH control, which showed a 
difference of less than 5mmHg.  
 
Although it is still unknown which medullary mechanism exactly explains why 
acupuncture lowers hypertension, we believe that opioids are important. Thus, 
future research is needed to measure the opioid levels in the medullary by doing 
immunohistochemistry and in situ hybridization. There are many neural pathways 
that EA stimulates, but we believe that the opioid mechanism is the main one that 
caused a rapid drop in blood pressure starting from the first week of EA 
treatment. We think that EA at S36-37 increased rVLM expression of enkephalin 
and endorphins. From previous studies, we have found that enkephalins and 
endorphins are associated with EA- activated neurons in the rVLM (Guo 2007). 
The opioids are associated with the inhibitory action of EA in rVLM via the μ- and 
δ-receptor. Endorphins and encephalin are important in modulating sympathetic 
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premotor neurons (Tjen-A-Looi, Peng Li, John C. Longhurst 2007).  A decrease 
in the sympathetic neurons will help reduce the blood pressure of the rats. 
Furthermore, because EA was able to reduce both the systolic and diastolic 
blood pressure, we predict that EA not only contribute to the reduced 
sympathetic response in the heart, but also arterial tone of the blood vessels via 
opioids. Opioids are able to decrease the arterial tone in the vessels and 
ultimately lower the diastolic blood pressure.  
 
Opioids have played a central role in lowering blood pressure not only for EA, but 
for pharmaceutical drugs as well. If the opioid mechanism is the main factor, then 
we predict that EA will lower the blood pressure for other hypertensive rat models 
as well. More research is needed to test the effect of other rat models, especially 
those that are genetically altered. However, we predict that similar effects will be 
seen because opioid peptide receptors are present in may cardiovascular control 
sites. Thus, EA will help activate and increase the expression of enkephalin and 
endorphin in other rat models. An increased expression of opioids will play a role 
in the EA inhibitory affect.   
 
Finally, the method that we used to apply electroacupuncture was successful 
because we were able to lower the blood pressures of the rats that underwent 
treatment. We believe that applying EA twice a week for 30 minutes at low 
voltage is a safe way to test on animals and hopefully on humans as well. It is not 
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necessary to restrain the subject during clinical trials, but it is important to 
monitor the voltage and safely inject the acupuncture needles into the correct 
acupoints. Because many people do not have time for two treatments a week, we 
may need to do future studies that require less frequent treatments.  
 
Overall, the data showed promising results in the ability of EA to lower blood 
pressure at the end of a 5 week treatment. There was a significant difference 
between the final systolic, diastolic, and mean blood pressures of the EA group 
compared to the Sham and Hypertensive control.  
 
Limitations:  
The overall sample size of the rats was small. Due to time and other limitations, 
we were not able to provide a bigger sample size for the experiment. This was a 
preliminary study, so more animals must be added to the sample size in the 
future. Some things to note is that the Normotensive control failed both of the 
ANOVA and T-test analysis. This is because we only had few rats for the 
Normotensive control, so the sample size may have been too small. The 
Normotensive control group was small because we were not able to handle a 
high number of rats in the laboratory. Due to time constraints, we were able to 
handle only 16 rats. We wanted more rats to be tested for the EA group in case 
some rats were nonresponsive to acupuncture (Li 2013).  The number of rats in 
the Hypertensive control group was also small compared to the EA and Sham 
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group due to restraints. However, other studies involving cold-induced 
hypertensive rats showed that rats placed in the cold-room with no treatment did 
not show a significant decrease in blood pressure 4 weeks after removal from the 
cold room (Shechtman 1990). Thus, we assumed that the CIH control group will 
not show a large decrease in blood pressure if we continued to house it in the 
cold-room without performing EA treatments. The results we obtained prove that 
the Hypertensive control group did not show a large decrease in blood pressure 
from week 7 to week 12. We can assume that if we had a larger pool of 
Hypertensive control rats, they will show similar results.  
 
Finally, the task of measuring the blood pressure of the rats was also very 
challenging. If the tail of the rats did not fit in the cuff correctly, some 
measurements may not have been accurate. Thus, we had to redo many blood 
pressure readings, which took sufficient time. During the experiment, the rats 
constantly moved, so the measurement of the heart rates may not be very 
accurate. Although the heart rates fluctuated, the range was normal for rats and 
should not have significant effect on the blood pressure drop.   
 
CONCLUSION 
 
Even with some limitations, we were able to demonstrate a significant effect of 
electroacupuncture on lowering blood pressure of chronic hypertensive rats. We 
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believe that the rapid decrease and prolonged retention of the depressed blood 
pressure after EA treatments were largely due to the opioid mechanism. Previous 
studies have shown that St 36-37 stimulate the rVLM, which ultimately increase 
the expression of endorphin and encephalin. These opioids act on the μ- and δ-
receptor to incite a cardiovascular inhibitory response. For future experiments, 
we can continue to expand the sample size and keep adding to the data. We can 
continue to follow the same method of measuring the rats’ blood pressures. We 
must increase the sample sizes for both normotensive and hypertensive control. 
Because the exact mechanism is still unclear, future research needs to be 
conducted to measure the expression of endorphin and enkephalin right after 8 
weeks of EA treatment. We need to look at the levels of opioids right after EA (24 
to 72 hours) and again several weeks after the last EA treatment. This way, we 
can understand more about the mechanism underlying the rapid decrease in 
blood pressure as well as the lasting effect of EA after several weeks. This can 
be done by collecting the brain tissue after the experiment and staining it for the 
desired opioids. Finally, it will be interesting to test EA on other models of 
hypertension such as those altered genetically or hormonally. Our lab focuses on 
environmentally induced hypertension in normal rats. Ultimately, the cause for 
high blood pressure in humans are associated with different factors. In order to 
prove that EA works as an alternative treatment for hypertension, we need to 
determine if EA works for a wide range of hypertensive models or only for those 
that are environmentally induced. Before we can conclude that EA is beneficial 
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for hypertension, we must determine what type of models or patients will respond 
to EA. As a result, it is necessary to expand the sample size and experiment with 
different animal models, not only those that have environmentally induced 
hypertension. More research is needed before experiment can be translated into 
clinical trials.  
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Appendix A: Data Analysis using One Way Anova and T-Tests 
 
SYSTOLIC BLOOD PRESSURE ANALYSIS  
 
Important Weeks:  
Week 2 or 3: Represent the initial blood pressure  
Week 7 or 8: Represent the elevated blood pressure after cold room (before treatment).  
Week 12: Represent the end of the experiment or after 5 weeks of treatment.  
 
Within One Group 
  
One Way Anova Test:  
 
EA: Normality Test: Passed  (P > 0.050) 
Comparisons for factor:  
Comparison Diff of Means t Unadjusted P Critical Level Significant?
  
Col 8 vs. Col 3 25.400 4.214 0.000 0.000 Yes  
Col 8 vs. Col 13 25.308 4.198 0.000 0.000 Yes  
Col 8 vs. Col 2 23.625 3.919 0.000 0.000 Yes  
Col 7 vs. Col 3 23.025 3.820 0.000 0.001 Yes  
Col 7 vs. Col 13 22.933 3.804 0.000 0.001 Yes  
 
Systolic Blood Pressure difference between week 7 and 12 was ~ 25.308.  
Systolic Blood Pressure difference between week 7 and 2 was ~ 25.4  
 
T-tests: 
 
Sham:  
Normality Test: Passed (P > 0.050) 
Group Name N  Missing Mean Std Dev SEM  
Col 24 6 1 161.580 6.253 2.797  
Col 20 6 1 140.420 7.014 3.137  
Difference 21.160 
Col 24 6 1 161.580 6.253 2.797  
Col 29 6 1 167.560 10.781 4.822  
Difference    -5.980 
Difference between week 3 and 7 was significant and ~ 21.160 
Difference between week 7 and week 12 was significant, but very small ~ 5.980  
 
Hypertensive Control:  
Normality Test: Passed (P > 0.050) 
Group Name N  Missing Mean Std Dev SEM  
Col 36 4 1 139.267 23.600 13.626  
Col 40 4 1 155.533 9.521 5.497  
Difference -16.267 
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Col 40 4 1 155.533 9.521 5.497  
Col 45 4 1 159.633 5.543 3.200  
Difference -4.100  
Difference between week 3 and 7 was significant and ~ 16.267  
Difference between week 7 and 12 was significant, but very small ~ 4.100 
 
Normotensive: Failed both One way Anova and T-test at week 3 vs 7 & week 7 vs 
12  
 
 
Between EA and Other Groups: 
 
T-Tests:  
 
EA/Sham:  
Normality Test: Passed (P > 0.050) 
Group Name N  Missing Mean Std Dev SEM  
Col 20 6 1 140.420 7.014 3.137  
Col 4              7  1 135.05       8.059      3.290 
Difference     5.370 
Col 8 7 1 157.242 9.985 4.076  
Col 24 6 1 161.580 6.253 2.797  
Difference -4.338  
Col 13 7 1 131.933 8.497 3.469  
Col 29 6 1 167.560 10.781 4.822  
Difference    -35.627 
Difference at week 3 was significant, but small ~ 5.370  
Difference at week 7 was significant, but small ~ 4.338  
Difference at week 12 was significant ~ 35.627 
 
 
EA/Hypertensive Control:  
Normality Test: Passed (P > 0.050) 
Group Name N  Missing Mean Std Dev SEM  
Col 4 7 1 135.050 8.059 3.290  
Col 36 4 1 139.267 23.600 13.626  
Difference -4.217 
 
Col 8 7 1 157.242 9.985 4.076  
Col 40 4 1 155.533 9.521 5.497  
Difference 1.708 
 
Col 13 7 1 131.933 8.497 3.469  
Col 45 4 1 159.633 5.543 3.200  
Difference -27.700 
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Difference at week 3 was significant, but small ~ 4.217  
Difference at week 7 was significant, but small ~ 1.708 
Difference at week 12 was significant ~ 27.700 
 
EA/Normotensive:  
Normality Test:  Passed (P > 0.050) 
Group Name N  Missing Mean Std Dev SEM  
Col 4 7 1 135.050 8.059 3.290  
Col 52 3 1 132.350 18.031 12.750  
Difference 2.700 
 
Col 56 3 1 130.000 2.828 2.000  
Col 8 7 1 157.242 9.985 4.076  
Difference -27.242 
 
Col 13 7 1 131.933 8.497 3.469  
Col 61 3 1 130.350 1.909 1.350  
Difference 1.583 
 
Difference at week 3 was significant, but small ~ 2.700 
Difference at week 7 was significant ~ 27.242 
Difference at week 12 was significant ~ 1.583 
 
 
 
DIASTOLIC BLOOD PRESSURE DATA ANALYSIS 
 
Within One Group 
 
T-Tests:  
 
EA:   
Normality Test: Passed (P > 0.050) 
Group Name N  Missing Mean Std Dev SEM  
Col 4 7 1 92.050 9.323 3.806  
Col 8 7 1 107.383 6.458 2.637  
Difference -15.333 
 
Col 13 7 1 91.633 14.250 5.818  
Col 8 7 1 107.383 6.458 2.637  
Difference -15.750 
 
Difference between week 3 and 7 was significant ~ 15.333  
Difference between week 7 and week 12 was significant, ~ 15.750 
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Sham:  
Normality Test: Passed (P > 0.050) 
 
Group Name N  Missing Mean Std Dev SEM  
Col 20 6 1 94.980 8.370 3.743  
Col 24 6 1 110.380 3.887 1.739  
Difference -15.400 
Col 24 6 1 161.580 6.253 2.797  
Col 29 6 1 167.560 10.781 4.822  
Difference -5.980 
Difference between week 3 and 7 was significant ~ 15.400 
Difference between week 7 and week 12 was significant, but small ~ 5.980 
 
Hypertensive Control:  
Normality Test: Passed (P > 0.050) 
 
Group Name N  Missing Mean Std Dev SEM  
Col 36 4 1 96.533 20.158 11.638  
Col 40 4 1 108.033 8.635 4.985  
Difference -11.500 
Col 40 4 1 108.033 8.635 4.985  
Col 45 4 1 110.900 5.730 3.308  
Difference -2.867 
 
Difference between week 3 and 7 was significant ~ 11.500  
Difference between week 7 and week 12 was significant, but small ~ 2.867 
 
Normotensive:  Failed both One way Anova and T-test at week 3 vs 7 & week 7 vs 
12 
 
Between EA and Other Groups: 
T-Tests:   
EA/Sham:  
Normality Test: Passed (P > 0.050) 
Group Name N  Missing Mean Std Dev SEM  
Col 4 7 1 92.050 9.323 3.806  
Col 20 6 1 94.980 8.370 3.743  
Difference -2.930 
 
Col 24 6 1 110.380 3.887 1.739  
Col 8 7 1 107.383 6.458 2.637  
Difference 2.997 
Col 29 6 1 114.820 12.182 5.448  
Col 13 7 1 91.633 14.250 5.818  
Difference 23.187 
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Difference at week 3 was significant, but small ~ 2.930  
Difference at week 7 was significant, but small ~ 2.997  
Difference at week 12 was significant ~ 23.187 
 
EA/Hypertensive Control:  
Normality Test: Passed (P > 0.050) 
Group Name N  Missing Mean Std Dev SEM  
Col 36 4 1 96.533 20.158 11.638  
Col 4 7 1 92.050 9.323 3.806  
Difference 4.483 
 
Col 40 4 1 108.033 8.635 4.985  
Col 8 7 1 107.383 6.458 2.637  
Difference 0.650 
 
Col 45 4 1 110.900 5.730 3.308  
Col 13 7 1 91.633 14.250 5.818  
Difference 19.267 
 
Difference at week 3 was significant, but small ~ 4.483 
Difference at week 7 was significant, but small ~ 0.650  
Difference at week 12 was significant ~ 19.267 
 
EA/Normotensive:  
Normality Test: Passed (P > 0.050) 
Group Name N  Missing Mean Std Dev SEM  
Col 52 3 1 85.500 14.142 10.000  
Col 4 7 1 92.050 9.323 3.806  
Difference -6.550 
 
Col 56 3 1 85.350 6.859 4.850  
Col 8 7 1 107.383 6.458 2.637  
Difference    -22.033 
 
Col 61 3 1 82.100 10.041 7.100  
Col 13 7 1 91.633 14.250 5.818  
Difference     -9.533 
Difference at week 3 was significant, but small ~ 6.550 
Difference at week 7 was significant, ~ 22.033  
Difference at week 12 was significant, but small ~ 9.533 
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MEAN BLOOD PRESSURE ANALYSIS  
 
Within One Group 
 
One Way Anova Test:  
 
EA:  
Normality Test: Passed (P > 0.050) 
Comparison Diff of Means t Unadjusted P Critical Level Significant?
  
Col 7 vs. Col 16 24.725 4.094 0.000 0.000 Yes  
Col 8 vs. Col 16 23.892 3.956 0.000 0.000 Yes  
Col 7 vs. Col 3 20.947 3.878 0.000 0.000 Yes  
Col 7 vs. Col 13 20.450 3.786 0.000 0.001 Yes  
Col 8 vs. Col 3               20.113        3.723             0.000           0.001   
Yes 
Mean Blood Pressure difference between week 2 and 7 was ~ 20.113  
Mean Blood Pressure difference between week 7 and 12 was ~ 23.892 
 
SHAM:  
Normality Test: Passed (P > 0.050) 
Comparison Diff of Means t Unadjusted P Critical Level
 Significant?  
Col 25 vs. Col 22 26.380 5.019 0.000 0.000 Yes  
Col 25 vs. Col 20 25.240 4.802 0.000 0.000 Yes  
Col 30 vs. Col 22 27.900 4.597 0.000 0.000 Yes  
Col 29 vs. Col 22 23.412 4.454 0.000 0.001 Yes  
Col 26 vs. Col 22 23.200 4.414 0.000 0.001 Yes  
Col 30 vs. Col 20 26.760 4.409 0.000 0.001 Yes  
Col 29 vs. Col 20 22.272 4.237 0.000 0.001 Yes  
Col 26 vs. Col 20 22.060 4.197 0.000 0.001 Yes  
Col 28 vs. Col 22 21.040 4.003 0.000 0.001 Yes  
 
Mean Blood Pressure difference between week 3 and 8 was ~ 25.240  
Mean Blood Pressure difference between week 3 and 12 was ~ 22.272 
 
T-Tests:  
 
SHAM:   
Normality Test: Passed (P > 0.050) 
Col 24 6 1 127.150 4.485 2.006  
Col 20 6 1 109.840 7.686 3.437  
Difference 17.310 
 
Difference between week 3 and 7 was significant ~ 17.310 
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Hypertensive Control:  
Normality Test: Passed (P > 0.050) 
 
Group Name N  Missing Mean Std Dev SEM  
Col 36 4 1 110.467 21.435 12.375  
Col 40 4 1 123.333 7.911 4.567  
Difference -12.867 
 
Col 40 4 1 123.333 7.911 4.567  
Col 45 4 1 126.767 5.389 3.111  
Difference -3.433 
 
Difference between week 3 and 7 was significant ~ 12.867  
Difference between week 7 and week 12 was significant, but small ~ 3.433 
 
Normotensive:  Failed both One way Anova and T-test at week 3 vs 7 & week 7 vs 
12 
 
 
Between EA and Other Groups: 
 
T-Tests:  
 
EA/Sham:  
Normality Test: Passed (P > 0.050) 
Group Name N  Missing Mean Std Dev SEM  
Col 20 6 1 109.840 7.686 3.437  
Col 4 7 1 106.067 8.269 3.376  
Difference 3.773 
Col 24 6 1 127.150 4.485 2.006  
Col 8 7 1 123.917 6.810 2.780  
Difference 3.233 
 
Col 29 6 1 132.112 11.433 5.113  
Col 13 7 1 104.300 8.325 3.399  
Difference 27.812 
 
Difference at week 3 was significant, but small ~ 3.773  
Difference at week 7 was significant, but small ~ 3.233  
Difference at week 12 was significant ~ 27.812 
 
EA/Hypertensive Control:  
Normality Test: Passed (P > 0.050) 
Group Name N  Missing Mean Std Dev SEM  
Col 36 4 1 110.467 21.435 12.375  
Col 4 7 1 106.067 8.269 3.376  
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Difference 4.400 
 
Col 40 4 1 123.333 7.911 4.567  
Col 8 7 1 123.917 6.810 2.780  
Difference -0.583 
 
Col 45 4 1 126.767 5.389 3.111  
Col 13 7 1 104.300 8.325 3.399  
Difference 22.467 
 
Difference at week 3 was significant, but small ~ 4.400  
Difference at week 7 was significant, but small ~ 0.583 
Difference at week 12 was significant ~ 22.467 
 
EA/Normotensive:  
Normality Test: Passed (P > 0.050) 
Group Name N  Missing Mean Std Dev SEM  
Col 52 3 1 100.000 15.556 11.000  
Col 4 7 1 106.067 8.269 3.376  
Difference -6.067 
 
Col 56 3 1 99.800 5.657 4.000  
Col 8 7 1 123.917 6.810 2.780  
Difference -24.117 
 
Col 61 3 1 97.850 5.869 4.150  
Col 13 7 1 104.300 8.325 3.399  
Difference -6.450 
 
Difference at week 3 was significant, but small ~ 6.067 
Difference at week 7 was significant, ~ 24.117 
Difference at week 12 was significant, but small ~ 6.450 
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